Anti-inflammatory properties of Septilin in lipopolysaccharide activated monocytes and macrophage

References

• Ernst, E. Prevalence of use of complementary/alternative medicine: a systematic review. Bull. World. Health. Organ. 2000, 78, 252–257.
   PubMed Web of Science ®Google Scholar
• Spelman, K., Burns, J., Nichols, D., Winters, N., Ottersberg, S., Tenborg, M. Modulation of cytokine expression by traditional medicines: a review of herbal immunomodulators. Altern. Med. Rev. 2006, 11, 128–150.
   PubMed Web of Science ®Google Scholar
• Gemsa, D., Leser, H.G., Seitz, M., Debatin, M., Bärlin, E., Deimann, W., Kramer, W. The role of macrophages in inflammation. Agents. Actions. Suppl. 1982, 11, 93–114.
   PubMedGoogle Scholar
• Ziegler, H.K., Staffileno, L.K., Wentworth, P. Modulation of macrophage Ia-expression by lipopolysaccharide. I. Induction of Ia expression in vivo. J. Immunol. 1984, 133, 1825–1835.
   PubMed Web of Science ®Google Scholar
• Chakravortty, D., Kumar, K.S. Interaction of lipopolysaccharide with human small intestinal lamina propria fibroblasts favors neutrophil migration and peripheral blood mononuclear cell adhesion by the production of proinflammatory mediators and adhesion molecules. Biochim. Biophys. Acta. 1999, 1453, 261–272.
   PubMed Web of Science ®Google Scholar
• Yin, L.L., Zhang, W.Y., Li, M.H., Shen, J.K., Zhu, X.Z. CC 05, a novel anti-inflammatory compound, exerts its effect by inhibition of cyclooxygenase-2 activity. Eur. J. Pharmacol. 2005, 520, 172–178.
   PubMedGoogle Scholar
• Heiss, E., Herhaus, C., Klimo, K., Bartsch, H., Gerhäuser, C. Nuclear factor kappa B is a molecular target for sulforaphane-mediated anti-inflammatory mechanisms. J. Biol. Chem. 2001, 276, 32008–32015.
   PubMed Web of Science ®Google Scholar
• Moncada, S., Palmer, R.M., Higgs, E.A. Nitric oxide: physiology, pathophysiology, and pharmacology. Pharmacol. Rev. 1991, 43, 109–142.
   PubMed Web of Science ®Google Scholar
• Niwa, M., Nakamura, N., Kitajima, K., Ueda, M., Tsutsumishita,Y., Futaki, S., Takaishi, Y. Benzoquinones inhibit the expression of inducible nitric oxide synthase gene. Biochem. Biophys. Res. Communi. 1997, 239, 367–371.
   PubMed Web of Science ®Google Scholar
• Needleman, P., Isakson, P.C. The discovery and function of COX-2. J. Rheumatol. Suppl. 1997, 49, 6–8.
   PubMedGoogle Scholar
• Crofford, L.J., Lipsky, P.E., Brooks, P., Abramson, S.B., Simon,L.S., van de Putte, L.B. Basic biology and clinical application of specific cyclooxygenase-2 inhibitors. Arthritis Rheum. 2000, 43, 4–13.
   PubMed Web of Science ®Google Scholar
• Shu-Jing, W.U., Lean-Teik, N.G. Tetrandrine inhibits proinflammatory cytokines, iNOS and COX-2 expression in human monocytic cells. Biol. Pharm. Bull. 2007, 30, 59–62.
   PubMedGoogle Scholar
• Souness, J.E., Aldous, D., Sargent, C. Immunosuppressive and anti-inflammatory effects of cyclic AMP phosphodiesterase (PDE) type 4 inhibitors. Immunopharmacology. 2000, 47, 127–162.
   PubMed Web of Science ®Google Scholar
• Essayan, D.M. Cyclic nucleotide phosphodiesterases. J. Allergy. Clin. Immunol. 2001, 108, 671–680.
   PubMed Web of Science ®Google Scholar
• Celli, B.COPD, inflammation and its modulation by phosphodiesterase 4 inhibitors: time to look beyond the FEV1. Chest. 2006, 129, 5–6.
   PubMed Web of Science ®Google Scholar
• Kroemer, G., Martínez, C. Cytokines and autoimmune disease. Clin. Immunol. Immunopathol. 1991, 61, 275–295.
   PubMedGoogle Scholar
• Medzhitov, R., Janeway, C.A. Jr. Decoding the patterns of self and nonself by the innate immune system. Science. 2002, 296, 298–300.
   PubMed Web of Science ®Google Scholar
• Kim, M.S., Yi, J.M., Kim, S.H., Hong, S.H., Kim, H.M. Madimadi, Korean folk medicine, blocks TNF-alpha, IL-1beta, and IL-8 production by activated human immune cells. Cytokine. 2004, 25, 179–186.
   PubMedGoogle Scholar
• Plaeger, S.F. Clinical immunology and traditional herbal medicines. Clin. Diag. Lab. Med. 2003, 10, 337–338.
   PubMedGoogle Scholar
• Praveenkumar V., Kuttan V., Kuttan G. Immunopotenitating activity of Septilin. Ind. J. Exp. Biology. 1997, 35, 1319–1323.
   PubMedGoogle Scholar
• Daswani, B.R., Yegnanarayan, R. Immunomodulatory activity of septilin, a polyherbal preparation. Phytother. Res. 2002, 16, 162–165.
   PubMed Web of Science ®Google Scholar
• Mitra, S.K., Varma, S.R., Godavarthi, A., Nandakumar, K.S. Liv.52 regulates ethanol induced PPARgamma and TNF alpha expression in HepG2 cells. Mol. Cell. Biochem. 2008, 315, 9–15.
   PubMed Web of Science ®Google Scholar
• Shiau, M.Y., Chiou, H.L., Lee, Y.L., Kuo, T.M., Chang, Y.H. Establishment of a consistent L929 bioassay system for TNF-alpha quantitation to evaluate the effect of lipopolysaccharide, phytomitogens and cytodifferentiation agents on cytotoxicity of TNF-alpha secreted by adherent human mononuclear cells. Mediators. Inflamm. 2001, 10, 199–208.
   PubMed Web of Science ®Google Scholar
• Chakravortty, D., Kumar, K.S. Induction of cell proliferation and collagen synthesis in human small intestinal lamina propria fibroblasts by lipopolysaccharide: possible involvement of nitric oxide. Biochem. Biophys. Res. Commun. 1997, 240, 458–463.
   PubMed Web of Science ®Google Scholar
• Peng, X., Mosser, D.M., Adler, M.W., Rogers, T.J., Meissler, J.J. Jr, Eisenstein, T.K. Morphine enhances interleukin-12 and the production of other pro-inflammatory cytokines in mouse peritoneal macrophages. J. Leukoc. Biol. 2000, 68, 723–728.
   PubMed Web of Science ®Google Scholar
• Sorli, C.H., Zhang, H.J., Armstrong, M.B., Rajotte, R.V., Maclouf, J., Robertson, R.P.Basal expression of cyclooxygenase-2 and nuclear factor-interleukin 6 are dominant and coordinately regulated by interleukin 1 in the pancreatic islet. Proc. Natl. Acad. Sci. U.S.A. 1998, 95, 1788–1793.
   PubMed Web of Science ®Google Scholar
• Méhats, C., Tanguy, G., Dallot, E., Robert, B., Rebourcet, R., Ferré,F., Leroy, M.J. Selective up-regulation of phosphodiesterase-4 cyclic adenosine 3′,5′-monophosphate (cAMP)-specific phosphodiesterase variants by elevated cAMP content in human myometrial cells in culture. Endocrinology. 1999, 140, 3228–3237.
   PubMedGoogle Scholar
• Klopotek, A., Hirche, F., Eder, K. PPAR gamma ligand troglitazone lowers cholesterol synthesis in HepG2 and Caco-2 cells via a reduced concentration of nuclear SREBP-2. Exp. Biol. Med. (Maywood) 2006, 231, 1365–1372.
   PubMed Web of Science ®Google Scholar
• Rathore, B., Ali Mahdi, A., Nath Paul, B., Narayan Saxena, P., Kumar Das, S. Indian herbal medicines: possible potent therapeutic agents for rheumatoid arthritis. J. Clin. Biochem. Nutr. 2007, 41, 12–17.
   PubMed Web of Science ®Google Scholar
• Soeken, K.L., Miller, S.A., Ernst, E. Herbal medicines for the treatment of rheumatoid arthritis: a systematic review. Rheumatology. (Oxford). 2003, 42, 652–659.
   PubMed Web of Science ®Google Scholar
• Grewal, D.S., Sharma, B.K., Shah, D.D., Sheode, J.H. Septilin and geriforte in allergic and vasomotor rhinitis Nasus A. Larynx. 1985, 12, 95–101.
   PubMedGoogle Scholar
• Khanna, N., Sharma, S.B. Anti-inflammatory and analgesic effect of herbal preparation: septilin. Ind. J. Med. Sci. 2001, 55, 195–202.
   PubMedGoogle Scholar
• Arend, W., Dayer, J. Cytokines and cytokine inhibitors or antagonists in rheumatoid arthritis. Arthritis. Rheum. 1990, 33, 305–315.
   PubMed Web of Science ®Google Scholar
• Moreland, L.W., Schiff, M.H., Baumgartner, S.W., Tindall, E.A., Fleischmann, R.M., Bulpitt, K.J., Weaver, A.L., Keystone, E.C., Furst, D.E., Mease, P.J., Ruderman, E.M., Horwitz, D.A., Arkfeld, D.G., Garrison, L., Burge, D.J., Blosch, C.M., Lange, M.L., McDonnell, N.D., Weinblatt, M.E. Etanercept therapy in rheumatoid arthritis. A randomized, controlled trial. Ann. Intern. Med. 1999, 30, 478–486.
   Google Scholar
• Ju, H.K., Baek, S.H., An, R.B., Bae, K., Son, K.H., Kim, H.P., Kang,S.S., Lee, S.H., Son, J.K., Chang, H.W. Inhibitory effects of nardostachin on nitric oxide, prostaglandin E2, and tumor necrosis factor-alpha production in lipopolysaccharide activated macrophages. Biol. Pharm. Bull. 2003, 26, 1375–1378.
   PubMedGoogle Scholar
• Chung, H.S., Kang, M., Cho, C., Parvez, S., Park, C.H., Kim, D., Oh, J., Kim, H., Shin, M., Hong, M., Kim, Y., Bae, H. Inhibition of nitric oxide and tumor necrosis factor-alpha by moutan cortex in activated mouse peritoneal macrophages. Biol. Pharm. Bull. 2007, 30, 912–916.
   PubMedGoogle Scholar
• Pant N., Jain, J.C. Inducible nitric oxide synthase (iNOs) inhibitors from plant. Ind. J. Pharm. Sci. 2002, 64, 183–190.
   Google Scholar
• Dirsch, V.M., Stuppner, H., Vollmar, A.M. The Griess assay: suitable for a bio-guided fractionation of anti-inflammatory plant extracts? Planta. Med. 1998, 64, 423–426.
   PubMed Web of Science ®Google Scholar
• Chakravortty, D., Kato, Y., Sugiyama, T., Koide, N., Mu, M.M., Yoshida, T., Yokochi, T. Inhibition of caspase 3 abrogates lipopolysaccharide-induced nitric oxide production by preventing activation of NF-kappaB and c-Jun NH2-terminal kinase/stress-activated protein kinase in RAW 264.7 murine macrophage cells. Infect. Immun. 2001, 69, 1315–1321.
   PubMed Web of Science ®Google Scholar
• Jagetia, G.C., Rao, S.K., Baliga, M.S., S Babu, K. The evaluation of nitric oxide scavenging activity of certain herbal formulations in vitro: a preliminary study. Phytother. Res. 2004, 18, 561–565.
   PubMed Web of Science ®Google Scholar
• Anderson, G.D., Hauser, S.D., McGarity, K.L., Bremer, M.E., Isakson, P.C., Gregory, S.A. Selective inhibition of cyclooxygenase (COX)-2 reverses inflammation and expression of COX-2 and interleukin 6 in rat adjuvant arthritis. J. Clin. Invest. 1996, 97, 2672–2679.
   PubMed Web of Science ®Google Scholar
• Amin, A.R., Attur, M., Patel, R.N., Thakker, G.D., Marshall,P.J., Rediske, J., Stuchin, S.A., Patel, I.R., Abramson, S.B. Superinduction of cyclooxygenase-2 activity in human osteoarthritis-affected cartilage. Influence of nitric oxide. J. Clin. Invest. 1997, 99, 1231–1237.
   PubMed Web of Science ®Google Scholar
• Dubois, R.N., Abramson, S.B., Crofford, L., Gupta, R.A., Simon,L.S., Van De Putte, L.B., Lipsky, P.E. Cyclooxygenase in biology and disease. FASEB. J. 1998, 12, 1063–1073.
   PubMed Web of Science ®Google Scholar
• Vane, J.R. Inhibition of prostaglandin synthesis as a mechanism of action for aspirin-like drugs. Nature. New. Biol. 1971, 231, 232–235.
   PubMedGoogle Scholar
• Murray, M.D., Brater, D.C. Renal toxicity of the nonsteroidal anti-inflammatory drugs. Annu. Rev. Pharmacol. Toxicol. 1993, 33, 435–465.
   PubMed Web of Science ®Google Scholar
• Barnes, P.J. Cyclic nucleotides and phosphodiesterases and airway function. Eur. Respir. J. 1995, 8, 457–462.
   PubMed Web of Science ®Google Scholar
• Teixeira, M.M., Gristwood, R.W., Cooper, N., Hellewell, P.G. Phosphodiesterase (PDE)4 inhibitors: anti-inflammatory drugs of the future? Trends. Pharmacol. Sci. 1997, 18, 164–171.
   PubMed Web of Science ®Google Scholar
• Jin, S.L., Conti, M.Induction of the cyclic nucleotide phosphodiesterase PDE4B is essential for LPS-activated TNF-alpha responses. Proc. Natl. Acad. Sci. U.S.A. 2002, 99, 7628–7633.
   PubMed Web of Science ®Google Scholar
• Ma, D., Wu, P., Egan, R.W., Billah, M.M., Wang, P. Phosphodiesterase 4B gene transcription is activated by lipopolysaccharide and inhibited by interleukin-10 in human monocytes. Mol. Pharmacol. 1999, 55, 50–57.
   PubMedGoogle Scholar
• Sinha, B., Semmler, J., Eisenhut, T., Eigler, A., Endres, S. Enhanced tumor necrosis factor suppression and cyclic adenosine monophosphate accumulation by combination of phosphodiesterase inhibitors and prostanoids. Eur. J. Immunol. 1995, 25, 147–153.
   PubMedGoogle Scholar
• Perkins, D.J., Kniss, D.A. Blockade of nitric oxide formation down-regulates cyclooxygenase-2 and decreases PGE2 biosynthesis in macrophages. J. Leukoc. Biol. 1999, 65, 792–799.
   PubMed Web of Science ®Google Scholar
• Skidgel, R.A., Gao, X.P., Brovkovych, V., Rahman, A., Jho, D., Predescu, S., Standiford, T.J., Malik, A.B. Nitric oxide stimulates macrophage inflammatory protein-2 expression in sepsis. J. Immunol. 2002, 169, 2093–2101.
   PubMed Web of Science ®Google Scholar